Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara McCready

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
JAMA|March 27, 2013
Combination therapy to prevent cardiovascular disease: slow progressRichard Smith, Tara McCready, Salim Yusuf
JAMA|August 31, 2013
Polypill for cardiovascular disease prevention--replyRichard Smith, Tara McCready, Salim Yusuf
Lancet (London, England)|August 3, 2020
Cardiovascular risk in hypertension: open questions about HOPE 4 - Authors' replyJon-David Schwalm, Tara McCready, Shofiqul Islam, et al.
Circulation. Cardiovascular Quality and Outcomes|March 5, 2024
Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 InterventionAnastasia Drakos, Tara McCready, Patricio Lopez-Jaramillo, et al.
Journal of Translational Medicine|August 20, 2016
Could patents interfere with the development of a cardiovascular polypill?Reed F Beall, Jon-David R Schwalm, Mark D Huffman, et al.
Cardiovascular Digital Health Journal|March 10, 2022
A machine learning-based clinical decision support algorithm for reducing unnecessary coronary angiogramsJ D Schwalm, Shuang Di, Tej Sheth, et al.
The Canadian Journal of Cardiology|September 18, 2010
Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitusJohn A Cairns, Salim Yusuf, Richard J Cook, et al.
JMIR Research Protocols|November 4, 2020
Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series StudyJ D Schwalm, Noah M Ivers, Zachary Bouck, et al.
Trials|February 22, 2011
Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working GroupLehana Thabane, George Wells, Richard Cook, et al.
CJC Open|March 29, 2021
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot StudyJon-David Schwalm, Tara McCready, Scott A Lear, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
JAMA|March 27, 2013
Combination therapy to prevent cardiovascular disease: slow progressRichard Smith, Tara McCready, Salim Yusuf
JAMA|August 31, 2013
Polypill for cardiovascular disease prevention--replyRichard Smith, Tara McCready, Salim Yusuf
Lancet (London, England)|August 3, 2020
Cardiovascular risk in hypertension: open questions about HOPE 4 - Authors' replyJon-David Schwalm, Tara McCready, Shofiqul Islam, et al.
Circulation. Cardiovascular Quality and Outcomes|March 5, 2024
Relationship Between Social Support and Clinical Outcomes: An Evaluation of Participant-Nominated Treatment Supporters in the HOPE 4 InterventionAnastasia Drakos, Tara McCready, Patricio Lopez-Jaramillo, et al.
Journal of Translational Medicine|August 20, 2016
Could patents interfere with the development of a cardiovascular polypill?Reed F Beall, Jon-David R Schwalm, Mark D Huffman, et al.
Cardiovascular Digital Health Journal|March 10, 2022
A machine learning-based clinical decision support algorithm for reducing unnecessary coronary angiogramsJ D Schwalm, Shuang Di, Tej Sheth, et al.
The Canadian Journal of Cardiology|September 18, 2010
Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitusJohn A Cairns, Salim Yusuf, Richard J Cook, et al.
JMIR Research Protocols|November 4, 2020
Length of Initial Prescription at Hospital Discharge and Long-Term Medication Adherence for Elderly, Post-Myocardial Infarction Patients: Protocol for an Interrupted Time Series StudyJ D Schwalm, Noah M Ivers, Zachary Bouck, et al.
Trials|February 22, 2011
Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working GroupLehana Thabane, George Wells, Richard Cook, et al.
CJC Open|March 29, 2021
Exploring New Models for Cardiovascular Risk Reduction: The Heart Outcomes Prevention and Evaluation 4 (HOPE 4) Canada Pilot StudyJon-David Schwalm, Tara McCready, Scott A Lear, et al.
Pageof 4